_id

695fbd85c2e91020a7bd43e9

Ticker

0LB2.LSE

Name

Supernus Pharmaceuticals, Inc.

Exchange

LSE

Address

9715 Key West Avenue, Rockville, MD, United States, 20850

Country

UK

Sector

Industry

Currency

USD

Website

https://www.supernus.com

Description

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States. The company offers Qelbree, a non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD); GOCOVRI for the treatment of dyskinesia and levodopa/carbidopa in patients with Parkinson's Disease (PD); Oxtellar XR, an extended-release oxcarbazepine product indicated for the monotherapy treatment of partial onset epilepsy seizures; and APOKYN for the acute and intermittent treatment of hypomobility or off episodes in patients with advanced PD. It also provides Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; XADAGO for the treatment of levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and chronic sialorrhea. In addition, the company develops ONAPGO, which received FDA approval, for the treatment of motor fluctuations in adults with advanced PD; SPN-817, a first-in-class selective acetylcholinesterase inhibitor, which is in Phase 2 clinical trial, for the treatment of epilepsy, partial seizures, Dravet syndrome, and Lennox-Gaustaut syndrome; SPN-820, a small molecule in Phase 2 clinical trial for treating resistant depression; SPN-443, a stimulant in Phase 1 trial for the treatment of ADHD/CNS; and SPN-446, a preclinical product for CNS. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development agreement with Navitor Inc. for the conduct of Phase 2 clinical program of SPN-820. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is based in Rockville, Maryland.

Last Close

51.2

Volume

156

Current Price

51.2

Change

2.25

Last Updated

2026-01-08T14:21:56.865Z

Ipo Date

-

Market Cap

218650854400

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

192103000

Cost Of Revenue

48331000

Gross Profit

143772000

Operating Expenses

204003000

Operating Income

-60231000

Interest Expense

-

Pretax Income

-57954000

Net Income

-45117000

Eps

-0.7977862646834395

Dividends Per Share

-

Shares Outstanding

52257000

Income Tax Expense

-12837000

EBITDA

-36596000

Operating Margin

-31.35349265758473

Total Other Income Expense Net

2277000

Cash

151371000

Short Term Investments

129788999

Receivables

171254000

Inventories

79399000

Total Current Assets

593891000

Property Plant Equipment

10627000

Total Assets

1419754000

Payables

108613000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

370087001

Equity

1049666999

Bs_currency_symbol

-

Depreciation

24806000

Change In Working Capital

-49200000

Cash From Operations

-61664000

Capital Expenditures

129000

Cash From Investing

48706000

Cash From Financing

21068000

Net Change In Cash

8110000

Cf_currency_symbol

-

PE

0.3725

PB

2.7584942100289847

ROE

-4.298220296816248

ROA

-3.1778040421087033

FCF

-61793000

Fcf Percent

-0.3216659812704643

Piotroski FScore

0

Health Score

34

Deep Value Investing Score

6

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

3.5

Growth Investing Score

2.5

Momentum Investing Score

5.5

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

8.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

192103000

Quarters > 0 > income Statement > cost Of Revenue

48331000

Quarters > 0 > income Statement > gross Profit

143772000

Quarters > 0 > income Statement > operating Expenses

204003000

Quarters > 0 > income Statement > operating Income

-60231000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-57954000

Quarters > 0 > income Statement > net Income

-45117000

Quarters > 0 > income Statement > eps

-0.7977862646834395

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

56552741

Quarters > 0 > income Statement > income Tax Expense

-12837000

Quarters > 0 > income Statement > EBITDA

-36596000

Quarters > 0 > income Statement > operating Margin

-31.35349265758473

Quarters > 0 > income Statement > total Other Income Expense Net

2277000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

151371000

Quarters > 0 > balance Sheet > short Term Investments

129788999

Quarters > 0 > balance Sheet > receivables

171254000

Quarters > 0 > balance Sheet > inventories

79399000

Quarters > 0 > balance Sheet > total Current Assets

593891000

Quarters > 0 > balance Sheet > property Plant Equipment

10627000

Quarters > 0 > balance Sheet > total Assets

1419754000

Quarters > 0 > balance Sheet > payables

108613000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

370087001

Quarters > 0 > balance Sheet > equity

1049666999

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

-45117000

Quarters > 0 > cash Flow > depreciation

24806000

Quarters > 0 > cash Flow > change In Working Capital

-49200000

Quarters > 0 > cash Flow > cash From Operations

-61664000

Quarters > 0 > cash Flow > capital Expenditures

129000

Quarters > 0 > cash Flow > cash From Investing

48706000

Quarters > 0 > cash Flow > cash From Financing

21068000

Quarters > 0 > cash Flow > net Change In Cash

8110000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-0.7977862646834395

Quarters > 0 > ratios > PB

2.7584942100289847

Quarters > 0 > ratios > ROE

-4.298220296816248

Quarters > 0 > ratios > ROA

-3.1778040421087033

Quarters > 0 > ratios > FCF

-61793000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-0.3216659812704643

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

165453000

Quarters > 1 > income Statement > cost Of Revenue

16827000

Quarters > 1 > income Statement > gross Profit

148626000

Quarters > 1 > income Statement > operating Expenses

136485000

Quarters > 1 > income Statement > operating Income

12141000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

16669000

Quarters > 1 > income Statement > net Income

22499000

Quarters > 1 > income Statement > eps

0.39720574348312204

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

56643189

Quarters > 1 > income Statement > income Tax Expense

-5830000

Quarters > 1 > income Statement > EBITDA

33499000

Quarters > 1 > income Statement > operating Margin

7.338035575057569

Quarters > 1 > income Statement > total Other Income Expense Net

4528000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

144711000

Quarters > 1 > balance Sheet > short Term Investments

377885000

Quarters > 1 > balance Sheet > receivables

140831000

Quarters > 1 > balance Sheet > inventories

44023000

Quarters > 1 > balance Sheet > total Current Assets

738866000

Quarters > 1 > balance Sheet > property Plant Equipment

11069000

Quarters > 1 > balance Sheet > total Assets

1382405000

Quarters > 1 > balance Sheet > payables

8215000

Quarters > 1 > balance Sheet > short Term Debt

7391000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

318505000

Quarters > 1 > balance Sheet > equity

1063900000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

22499000

Quarters > 1 > cash Flow > depreciation

21358000

Quarters > 1 > cash Flow > change In Working Capital

11492000

Quarters > 1 > cash Flow > cash From Operations

58535000

Quarters > 1 > cash Flow > capital Expenditures

455000

Quarters > 1 > cash Flow > cash From Investing

-30607000

Quarters > 1 > cash Flow > cash From Financing

935000

Quarters > 1 > cash Flow > net Change In Cash

28863000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

0.39720574348312204

Quarters > 1 > ratios > PB

2.725943487921797

Quarters > 1 > ratios > ROE

2.1147664254159224

Quarters > 1 > ratios > ROA

1.6275259421081374

Quarters > 1 > ratios > FCF

58080000

Quarters > 1 > ratios > Piotroski FScore

4

Quarters > 1 > ratios > fcf Percent

0.3510362459429566

Quarters > 1 > health Score

73

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

149824000

Quarters > 2 > income Statement > cost Of Revenue

15763000

Quarters > 2 > income Statement > gross Profit

134061000

Quarters > 2 > income Statement > operating Expenses

144317000

Quarters > 2 > income Statement > operating Income

-10256000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-5831000

Quarters > 2 > income Statement > net Income

-11827000

Quarters > 2 > income Statement > eps

-0.2117079603696732

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

55864692

Quarters > 2 > income Statement > income Tax Expense

5996000

Quarters > 2 > income Statement > EBITDA

17787000

Quarters > 2 > income Statement > operating Margin

-6.845365228534813

Quarters > 2 > income Statement > total Other Income Expense Net

4425000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

115848000

Quarters > 2 > balance Sheet > short Term Investments

347742000

Quarters > 2 > balance Sheet > receivables

145640000

Quarters > 2 > balance Sheet > inventories

49423000

Quarters > 2 > balance Sheet > total Current Assets

687584000

Quarters > 2 > balance Sheet > property Plant Equipment

11338000

Quarters > 2 > balance Sheet > total Assets

1347290000

Quarters > 2 > balance Sheet > payables

7072000

Quarters > 2 > balance Sheet > short Term Debt

5937000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

316585000

Quarters > 2 > balance Sheet > equity

1030705000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

-11827000

Quarters > 2 > cash Flow > depreciation

20383000

Quarters > 2 > cash Flow > change In Working Capital

13906000

Quarters > 2 > cash Flow > cash From Operations

30599000

Quarters > 2 > cash Flow > capital Expenditures

327000

Quarters > 2 > cash Flow > cash From Investing

37317000

Quarters > 2 > cash Flow > cash From Financing

-21399000

Quarters > 2 > cash Flow > net Change In Cash

46517000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.2117079603696732

Quarters > 2 > ratios > PB

2.7750638935485905

Quarters > 2 > ratios > ROE

-1.1474670249974532

Quarters > 2 > ratios > ROA

-0.8778362490629337

Quarters > 2 > ratios > FCF

30272000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

0.20205040580948314

Quarters > 2 > health Score

54

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

174159000

Quarters > 3 > income Statement > cost Of Revenue

26098000

Quarters > 3 > income Statement > gross Profit

148061000

Quarters > 3 > income Statement > operating Expenses

126656000

Quarters > 3 > income Statement > operating Income

21405000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

26382000

Quarters > 3 > income Statement > net Income

15328000

Quarters > 3 > income Statement > eps

0.2714613119458846

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

56464768

Quarters > 3 > income Statement > income Tax Expense

11054000

Quarters > 3 > income Statement > EBITDA

45227000

Quarters > 3 > income Statement > operating Margin

12.29049317003428

Quarters > 3 > income Statement > total Other Income Expense Net

4977000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

69331000

Quarters > 3 > balance Sheet > short Term Investments

384281000

Quarters > 3 > balance Sheet > receivables

142077000

Quarters > 3 > balance Sheet > inventories

54293000

Quarters > 3 > balance Sheet > total Current Assets

686070000

Quarters > 3 > balance Sheet > property Plant Equipment

11545000

Quarters > 3 > balance Sheet > total Assets

1368073000

Quarters > 3 > balance Sheet > payables

4587000

Quarters > 3 > balance Sheet > short Term Debt

6889000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

332340000

Quarters > 3 > balance Sheet > equity

1035733000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

15328000

Quarters > 3 > cash Flow > depreciation

18845000

Quarters > 3 > cash Flow > change In Working Capital

-5129000

Quarters > 3 > cash Flow > cash From Operations

44406000

Quarters > 3 > cash Flow > capital Expenditures

213000

Quarters > 3 > cash Flow > cash From Investing

-12638000

Quarters > 3 > cash Flow > cash From Financing

5890000

Quarters > 3 > cash Flow > net Change In Cash

37658000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

0.2714613119458846

Quarters > 3 > ratios > PB

2.791256165054121

Quarters > 3 > ratios > ROE

1.4799180869973247

Quarters > 3 > ratios > ROA

1.120408048400926

Quarters > 3 > ratios > FCF

44193000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.25375088281398034

Quarters > 3 > health Score

72

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

661817000

Annuals > 0 > income Statement > cost Of Revenue

77906000

Annuals > 0 > income Statement > gross Profit

583911000

Annuals > 0 > income Statement > operating Expenses

502245000

Annuals > 0 > income Statement > operating Income

81666000

Annuals > 0 > income Statement > interest Expense

-

Annuals > 0 > income Statement > pretax Income

97870000

Annuals > 0 > income Statement > net Income

73865000

Annuals > 0 > income Statement > eps

1.3199842742007541

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

55959000

Annuals > 0 > income Statement > income Tax Expense

24005000

Annuals > 0 > income Statement > EBITDA

178284000

Annuals > 0 > income Statement > operating Margin

12.339664892258737

Annuals > 0 > income Statement > total Other Income Expense Net

16204000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

69331000

Annuals > 0 > balance Sheet > short Term Investments

384281000

Annuals > 0 > balance Sheet > receivables

142077000

Annuals > 0 > balance Sheet > inventories

54293000

Annuals > 0 > balance Sheet > total Current Assets

686070000

Annuals > 0 > balance Sheet > property Plant Equipment

11545000

Annuals > 0 > balance Sheet > total Assets

1368073000

Annuals > 0 > balance Sheet > payables

4587000

Annuals > 0 > balance Sheet > short Term Debt

6889000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

332340000

Annuals > 0 > balance Sheet > equity

1035733000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

73865000

Annuals > 0 > cash Flow > depreciation

80414000

Annuals > 0 > cash Flow > change In Working Capital

-2052000

Annuals > 0 > cash Flow > cash From Operations

171951000

Annuals > 0 > cash Flow > capital Expenditures

725000

Annuals > 0 > cash Flow > cash From Investing

-189867000

Annuals > 0 > cash Flow > cash From Financing

12193000

Annuals > 0 > cash Flow > net Change In Cash

-5723000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

1.3199842742007541

Annuals > 0 > ratios > PB

2.766254237337229

Annuals > 0 > ratios > ROE

7.131664241653013

Annuals > 0 > ratios > ROA

5.39920018887881

Annuals > 0 > ratios > FCF

171226000

Annuals > 0 > ratios > Piotroski FScore

3

Annuals > 0 > ratios > fcf Percent

0.2587210663975087

Annuals > 0 > health Score

79

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

607521000

Annuals > 1 > income Statement > cost Of Revenue

83779000

Annuals > 1 > income Statement > gross Profit

523742000

Annuals > 1 > income Statement > operating Expenses

529011000

Annuals > 1 > income Statement > operating Income

-5269000

Annuals > 1 > income Statement > interest Expense

2415000

Annuals > 1 > income Statement > pretax Income

2769000

Annuals > 1 > income Statement > net Income

1316000

Annuals > 1 > income Statement > eps

0.023708794889162103

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

55506828

Annuals > 1 > income Statement > income Tax Expense

1453000

Annuals > 1 > income Statement > EBITDA

90043000

Annuals > 1 > income Statement > operating Margin

-0.8672951223085293

Annuals > 1 > income Statement > total Other Income Expense Net

8038000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

75054000

Annuals > 1 > balance Sheet > short Term Investments

179820000

Annuals > 1 > balance Sheet > receivables

144155000

Annuals > 1 > balance Sheet > inventories

77408000

Annuals > 1 > balance Sheet > total Current Assets

493113000

Annuals > 1 > balance Sheet > property Plant Equipment

13530000

Annuals > 1 > balance Sheet > total Assets

1277673000

Annuals > 1 > balance Sheet > payables

1964000

Annuals > 1 > balance Sheet > short Term Debt

8331000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

356157000

Annuals > 1 > balance Sheet > equity

921516000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

1316000

Annuals > 1 > cash Flow > depreciation

84859000

Annuals > 1 > cash Flow > change In Working Capital

-9137000

Annuals > 1 > cash Flow > cash From Operations

111085000

Annuals > 1 > cash Flow > capital Expenditures

551000

Annuals > 1 > cash Flow > cash From Investing

268729000

Annuals > 1 > cash Flow > cash From Financing

-397880000

Annuals > 1 > cash Flow > net Change In Cash

-18066000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

0.023708794889162103

Annuals > 1 > ratios > PB

3.083993759847903

Annuals > 1 > ratios > ROE

0.1428081552572066

Annuals > 1 > ratios > ROA

0.10299975032735294

Annuals > 1 > ratios > FCF

110534000

Annuals > 1 > ratios > Piotroski FScore

3

Annuals > 1 > ratios > fcf Percent

0.18194268181676024

Annuals > 1 > health Score

62

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

667238000

Annuals > 2 > income Statement > cost Of Revenue

87221000

Annuals > 2 > income Statement > gross Profit

580017000

Annuals > 2 > income Statement > operating Expenses

533893000

Annuals > 2 > income Statement > operating Income

46124000

Annuals > 2 > income Statement > interest Expense

7070000

Annuals > 2 > income Statement > pretax Income

60743000

Annuals > 2 > income Statement > net Income

60711000

Annuals > 2 > income Statement > eps

0.9842930748802687

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

61679800

Annuals > 2 > income Statement > income Tax Expense

32000

Annuals > 2 > income Statement > EBITDA

153356000

Annuals > 2 > income Statement > operating Margin

6.912675836807855

Annuals > 2 > income Statement > total Other Income Expense Net

14619000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

93120000

Annuals > 2 > balance Sheet > short Term Investments

368214000

Annuals > 2 > balance Sheet > receivables

165497000

Annuals > 2 > balance Sheet > inventories

91541000

Annuals > 2 > balance Sheet > total Current Assets

734151000

Annuals > 2 > balance Sheet > property Plant Equipment

15173000

Annuals > 2 > balance Sheet > total Assets

1702508000

Annuals > 2 > balance Sheet > payables

10543000

Annuals > 2 > balance Sheet > short Term Debt

408759000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

816304000

Annuals > 2 > balance Sheet > equity

886204000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

60711000

Annuals > 2 > cash Flow > depreciation

85543000

Annuals > 2 > cash Flow > change In Working Capital

-24243000

Annuals > 2 > cash Flow > cash From Operations

116826000

Annuals > 2 > cash Flow > capital Expenditures

412000

Annuals > 2 > cash Flow > cash From Investing

-216663000

Annuals > 2 > cash Flow > cash From Financing

-10477000

Annuals > 2 > cash Flow > net Change In Cash

-110314000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

0.9842930748802687

Annuals > 2 > ratios > PB

3.5635200924392127

Annuals > 2 > ratios > ROE

6.850679978876196

Annuals > 2 > ratios > ROA

3.565974433012943

Annuals > 2 > ratios > FCF

116414000

Annuals > 2 > ratios > Piotroski FScore

3

Annuals > 2 > ratios > fcf Percent

0.1744714779434025

Annuals > 2 > health Score

65

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

579775000

Annuals > 3 > income Statement > cost Of Revenue

75061000

Annuals > 3 > income Statement > gross Profit

504714000

Annuals > 3 > income Statement > operating Expenses

418685000

Annuals > 3 > income Statement > operating Income

86029000

Annuals > 3 > income Statement > interest Expense

23423000

Annuals > 3 > income Statement > pretax Income

73175000

Annuals > 3 > income Statement > net Income

53424000

Annuals > 3 > income Statement > eps

0.9828403261240224

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

54356744

Annuals > 3 > income Statement > income Tax Expense

19751000

Annuals > 3 > income Statement > EBITDA

129193000

Annuals > 3 > income Statement > operating Margin

14.83834246043724

Annuals > 3 > income Statement > total Other Income Expense Net

-12854000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

203434000

Annuals > 3 > balance Sheet > short Term Investments

136246000

Annuals > 3 > balance Sheet > receivables

148932000

Annuals > 3 > balance Sheet > inventories

85959000

Annuals > 3 > balance Sheet > total Current Assets

601590000

Annuals > 3 > balance Sheet > property Plant Equipment

16955000

Annuals > 3 > balance Sheet > total Assets

1689152000

Annuals > 3 > balance Sheet > payables

9331000

Annuals > 3 > balance Sheet > short Term Debt

6477000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

873301000

Annuals > 3 > balance Sheet > equity

815851000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

53424000

Annuals > 3 > cash Flow > depreciation

32595000

Annuals > 3 > cash Flow > change In Working Capital

3570000

Annuals > 3 > cash Flow > cash From Operations

127127000

Annuals > 3 > cash Flow > capital Expenditures

2045000

Annuals > 3 > cash Flow > cash From Investing

-81913000

Annuals > 3 > cash Flow > cash From Financing

-130420000

Annuals > 3 > cash Flow > net Change In Cash

-85206000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

0.9828403261240224

Annuals > 3 > ratios > PB

3.411242117494494

Annuals > 3 > ratios > ROE

6.548254521965408

Annuals > 3 > ratios > ROA

3.162770431553821

Annuals > 3 > ratios > FCF

125082000

Annuals > 3 > ratios > Piotroski FScore

3

Annuals > 3 > ratios > fcf Percent

0.21574231382864043

Annuals > 3 > health Score

61

Valuation > metrics > PE

0.3725

Valuation > metrics > PB

2.7584942100289847

Valuation > final Score

100

Valuation > verdict

48.1% Undervalued

Profitability > metrics > ROE

-4.298220296816248

Profitability > metrics > ROA

-7.596848579958275

Profitability > metrics > Net Margin

-0.2348583832631453

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3525756276538899

Risk > metrics > Interest Coverage

-2.8200674220432624

Risk > final Score

49

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.467955033007098

Liquidity > metrics > Quick Ratio

4.736928360325192

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

100

Prev Valuations > 1

80

Prev Valuations > 2

100

Prev Profitabilities > 0

34

Prev Profitabilities > 1

0

Prev Profitabilities > 2

23

Prev Risks > 0

63

Prev Risks > 1

58

Prev Risks > 2

65

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:58.631Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-24

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

0.4

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-